Dash Bio
Dash Bio is revolutionizing drug development by leveraging AI, robotics, and integrated software to accelerate the process. Their initial offering is a highly automated clinical bioanalysis lab providing GLP-compliant services with unparalleled speed, aiming to reduce the time and cost of bringing new drugs to market.
Funding Round: Seed
Funding Amount: $6.5M
Date: 24-Oct-2024
Investors: Freestyle Capital, Swift Ventures, LifeX Ventures, other private investors
Markets: Biotech, AI
HQ: Boston, Massachusetts, United States
Founded: 2024
Website: https://dash.bio/
LinkedIn: https://www.linkedin.com/company/dashbio
Crunchbase: https://www.crunchbase.com/organization/dash-bio
Leave a Comment
Comments
No comments yet.